181 related articles for article (PubMed ID: 30727875)
1. Pharmacotherapy for Choroidal Neovascularization Due to Uncommon Causes.
Ho CPS; Lai TYY
Curr Pharm Des; 2018; 24(41):4882-4895. PubMed ID: 30727875
[TBL] [Abstract][Full Text] [Related]
2. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of Myopic Choroidal Neovascularization.
Isildak H; Schwartz SG; Flynn HW
Curr Pharm Des; 2018; 24(41):4853-4859. PubMed ID: 30674251
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia.
Pakzad-Vaezi K; Mehta H; Mammo Z; Tufail A
Expert Opin Biol Ther; 2016 Jul; 16(7):873-81. PubMed ID: 26985834
[TBL] [Abstract][Full Text] [Related]
5. Different effects of anti-VEGF drugs (Ranibizumab, Aflibercept, Conbercept) on autophagy and its effect on neovascularization in RF/6A cells.
Wang Y; Yao Y; Li R; Wu B; Lu H; Cheng J; Liu Z; Du J
Microvasc Res; 2021 Nov; 138():104207. PubMed ID: 34119535
[TBL] [Abstract][Full Text] [Related]
6. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy for choroidal neovascularisation.
Augustin AJ; Offermann I
Drugs Aging; 2007; 24(12):979-90. PubMed ID: 18020531
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
Emerson MV; Lauer AK
BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
[TBL] [Abstract][Full Text] [Related]
10. Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization.
Ng DSC; Ho M; Iu LPL; Lai TYY
Expert Opin Drug Saf; 2022 Jan; 21(1):43-54. PubMed ID: 34228553
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration.
Roller AB; Amaro MH
Arq Bras Oftalmol; 2009; 72(5):677-81. PubMed ID: 20027409
[TBL] [Abstract][Full Text] [Related]
12. Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre.
Rishi P; Rishi E; Bhende M; Agarwal V; Vyas CH; Valiveti M; Bhende P; Rao C; Susvar P; Sen P; Raman R; Khetan V; Murali V; Ratra D; Sharma T
Br J Ophthalmol; 2016 Oct; 100(10):1337-40. PubMed ID: 26792945
[TBL] [Abstract][Full Text] [Related]
13. Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application.
Zhang Y; Han Q; Ru Y; Bo Q; Wei RH
Drug Des Devel Ther; 2015; 9():3413-21. PubMed ID: 26170626
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for choroidal neovascularisation secondary to causes other than age-related macular degeneration.
Gupta B; Elagouz M; Sivaprasad S
Eye (Lond); 2010 Feb; 24(2):203-13. PubMed ID: 19662081
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and treatment outcomes of angioid streak associated choroidal neovascular membrane (AS-CNV): a Zambian case series.
Kumar K; Balasubramaniam S; Agarwal A
Pan Afr Med J; 2020; 36():294. PubMed ID: 33117488
[TBL] [Abstract][Full Text] [Related]
16. Aflibercept for the treatment of neovascular age-related macular degeneration.
Verner-Cole EA; Davis SJ; Lauer AK
Drugs Today (Barc); 2012 May; 48(5):317-29. PubMed ID: 22645720
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
Kourlas H; Abrams P
Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
[TBL] [Abstract][Full Text] [Related]
18. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VERSUS PHOTODYNAMIC THERAPY IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO CENTRAL SEROUS CHORIORETINOPATHY.
Peiretti E; Caminiti G; Serra R; Querques L; Pertile R; Querques G
Retina; 2018 Aug; 38(8):1526-1532. PubMed ID: 28699928
[TBL] [Abstract][Full Text] [Related]
19. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia.
Hashemi S; Faramarzi MA; Ghasemi Falavarjani K; Abdollahi M
Expert Opin Biol Ther; 2014 Dec; 14(12):1837-48. PubMed ID: 25283631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
